Pharmaceutical composition capable of reducing blood fat

Abstract

The invention relates to a pharmaceutical composition capable of reducing blood fat. The pharmaceutical composition is prepared from the following raw materials: radix bupleuri, radix astragali, mulberry leaf, roots of kudzu vine, poria cocos, roots of red-rooted salvia, liquorice root, lantern plant calyx, radish seeds and herba cistanches. The pharmaceutical composition has the beneficial effects that: the raw materials are prepared from natural medicines, and the components are compounded, so that the blood fat reducing function of the pharmaceutical composition is greatly improved, the curative effect is quick, the cost is low, and the toxic and side effect is reduced.

Description

technical field

[0001] The invention relates to the technical field of traditional Chinese medicines, in particular to a pharmaceutical composition capable of reducing the blood lipid content of a human body. Background technique

[0002] With the acceleration of the industrialization process, people's material life has been greatly improved. While enjoying the material civilization brought about by economic development, human beings feel more and more that the doom brought by material enjoyment is approaching. Hyperlipidemia caused by one's own bad life behavior has become the main threat factor of modern diseases. Atherosclerosis caused by hyperlipidemia is the main cause of coronary heart disease, hypertension and cardiovascular and cerebrovascular diseases.

[0003] At present, the treatment of hyperlipidemia is mainly to take western medicine. There are two main types of western medicine lipid-lowering drugs, statins mainly for lowering total cholesterol and low-densit...

Examples

Embodiment 1

[0036] The present embodiment provides a blood lipid-lowering pharmaceutical composition, comprising the following components in parts by weight: 25 parts of Bupleurum, 25 parts of Huangshi, 20 parts of mulberry leaves, 15 parts of Pueraria lobata, 15 parts of Poria cocos, 13 parts of Salvia miltiorrhiza, 13 parts of licorice , 8 servings of hanging golden lanterns, 8 servings of radish seeds, and 8 servings of meat hibiscus.

[0037] The above-mentioned blood lipid-lowering pharmaceutical composition is made into granules, and the specific preparation process is as follows:

[0038] (1) mixing the raw materials, then ultrafine pulverizing;

[0039] (2) Add an appropriate amount of water to the above-mentioned superfine powder and knead;

[0040] (3) The granulator granulates the above-mentioned medicine after kneading;

[0041] (4) Dry the above-mentioned granules, granulate, and sub-package to make granules.

Embodiment 2

[0043] The present embodiment provides a blood lipid-lowering pharmaceutical composition, comprising the following components in parts by weight: 20 parts of Bupleurum bupleuri, 30 parts of Huangshi, 10 parts of mulberry leaves, 20 parts of Pueraria lobata, 20 parts of Poria cocos, 10 parts of salvia miltiorrhiza, 10 parts of licorice , 10 servings of hanging golden lanterns, 10 servings of radish seeds, and 5 servings of meat hibiscus.

[0044] The above-mentioned blood lipid-lowering pharmaceutical composition is made into granules, and the specific preparation process is as follows:

[0045] (1) mixing the raw materials, then ultrafine pulverizing;

[0046] (2) Add an appropriate amount of water to the above-mentioned superfine powder and knead;

[0047] (3) The granulator granulates the above-mentioned medicine after kneading;

[0048] (4) Dry the above-mentioned granules, granulate, and sub-package to make granules.

Embodiment 3

[0050] The present embodiment provides a blood lipid-lowering pharmaceutical composition, comprising the following components in parts by weight: 35 parts of Bupleurum bupleuri, 15 parts of Huangshi, 25 parts of mulberry leaves, 10 parts of kudzu root, 10 parts of Poria cocos, 15 parts of salvia miltiorrhiza, 15 parts of licorice , 5 servings of hanging golden lanterns, 50 servings of radish seeds, and 10 servings of meat hibiscus.

[0051] The above-mentioned blood lipid-lowering pharmaceutical composition is made into granules, and the specific preparation process is as follows:

[0052] (1) mixing the raw materials, then ultrafine pulverizing;

[0053](2) Add an appropriate amount of water to the above-mentioned superfine powder and knead;

[0054] (3) The granulator granulates the above-mentioned medicine after kneading;

[0055] (4) Dry the above-mentioned granules, granulate, and sub-package to make granules.

[0056] The blood lipid-lowering pharmaceutical compositio...

technical field

[0001] The invention relates to the technical field of traditional Chinese medicines, in particular to a pharmaceutical composition capable of reducing the blood lipid content of a human body. Background technique

[0002] With the acceleration of the industrialization process, people's material life has been greatly improved. While enjoying the material civilization brought about by economic development, human beings feel more and more that the doom brought by material enjoyment is approaching. Hyperlipidemia caused by one's own bad life behavior has become the main threat factor of modern diseases. Atherosclerosis caused by hyperlipidemia is the main cause of coronary heart disease, hypertension and cardiovascular and cerebrovascular diseases.

[0003] At present, the treatment of hyperlipidemia is mainly to take western medicine. There are two main types of western medicine lipid-lowering drugs, statins mainly for lowering total cholesterol and low-densit...

Examples

Embodiment 1

[0036] The present embodiment provides a blood lipid-lowering pharmaceutical composition, comprising the following components in parts by weight: 25 parts of Bupleurum, 25 parts of Huangshi, 20 parts of mulberry leaves, 15 parts of Pueraria lobata, 15 parts of Poria cocos, 13 parts of Salvia miltiorrhiza, 13 parts of licorice , 8 servings of hanging golden lanterns, 8 servings of radish seeds, and 8 servings of meat hibiscus.

[0037] The above-mentioned blood lipid-lowering pharmaceutical composition is made into granules, and the specific preparation process is as follows:

[0038] (1) mixing the raw materials, then ultrafine pulverizing;

[0039] (2) Add an appropriate amount of water to the above-mentioned superfine powder and knead;

[0040] (3) The granulator granulates the above-mentioned medicine after kneading;

[0041] (4) Dry the above-mentioned granules, granulate, and sub-package to make granules.

Embodiment 2

[0043] The present embodiment provides a blood lipid-lowering pharmaceutical composition, comprising the following components in parts by weight: 20 parts of Bupleurum bupleuri, 30 parts of Huangshi, 10 parts of mulberry leaves, 20 parts of Pueraria lobata, 20 parts of Poria cocos, 10 parts of salvia miltiorrhiza, 10 parts of licorice , 10 servings of hanging golden lanterns, 10 servings of radish seeds, and 5 servings of meat hibiscus.

[0044] The above-mentioned blood lipid-lowering pharmaceutical composition is made into granules, and the specific preparation process is as follows:

[0045] (1) mixing the raw materials, then ultrafine pulverizing;

[0046] (2) Add an appropriate amount of water to the above-mentioned superfine powder and knead;

[0047] (3) The granulator granulates the above-mentioned medicine after kneading;

[0048] (4) Dry the above-mentioned granules, granulate, and sub-package to make granules.

Embodiment 3

[0050] The present embodiment provides a blood lipid-lowering pharmaceutical composition, comprising the following components in parts by weight: 35 parts of Bupleurum bupleuri, 15 parts of Huangshi, 25 parts of mulberry leaves, 10 parts of kudzu root, 10 parts of Poria cocos, 15 parts of salvia miltiorrhiza, 15 parts of licorice , 5 servings of hanging golden lanterns, 50 servings of radish seeds, and 10 servings of meat hibiscus.

[0051] The above-mentioned blood lipid-lowering pharmaceutical composition is made into granules, and the specific preparation process is as follows:

[0052] (1) mixing the raw materials, then ultrafine pulverizing;

[0053](2) Add an appropriate amount of water to the above-mentioned superfine powder and knead;

[0054] (3) The granulator granulates the above-mentioned medicine after kneading;

[0055] (4) Dry the above-mentioned granules, granulate, and sub-package to make granules.

[0056] The blood lipid-lowering pharmaceutical compositio...